Pneumococcal vaccination in welders

Childhood pneumococcal vaccination in Europe.

Invasive diseases caused by Streptococcus pneumoniae (pneumococcus) are a major public health issue in Europe as well as worldwide. Severe diseases caused by pneumococci are pneumonia, meningitis and febrile bacteraemia; otitis media is a more common, but less serious manifestation of pneumococcal infection. Pneumococcus can affect all age groups but the bigger burden of disease is among childr...

Pneumococcal Vaccination in Different Specialties.

P disease can be dangerous, and sometimes fatal, in people above the age of 50 years and with certain chronic medical condit ions . This may be true even when the chronic medical condition is well controlled with medication and/or lifestyle m a n a g e m e n t . P n e u m o c o c c a l vaccination needs to be used more consistently to reduce the risk of pneumococcal infection in these indiv idu...

Pneumococcal vaccination in developing countries.

Navigating pneumococcal vaccination in adults.

With two nonequivalent vaccines available and different recommendations for different patient populations, vaccination against Streptococcus pneumoniae can be confusing. Here we try to clarify the situation.

Pneumococcal vaccination policy in Europe.

Infection due to Streptococcus pneumoniae (Pneumococcus) (Pnc) is an important cause of invasive clinical manifestations such as meningitis, septicaemia and pneumonia, particularly in young children and the elderly. A 23-valent polysaccharide Pnc vaccine (PPV) has been available for many years and a 7-valent conjugate Pnc vaccine (PCV) has been licensed since 2001 in Europe. As part of a Europe...